These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8527002)
1. Effect of age and disease duration on parkinsonian motor scores under levodopa therapy. Ransmayr G; Künig G; Neubauer M; Wagner M; Falk M J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):177-88. PubMed ID: 8527002 [TBL] [Abstract][Full Text] [Related]
2. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998 [TBL] [Abstract][Full Text] [Related]
3. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890 [TBL] [Abstract][Full Text] [Related]
4. Differential progression of motor impairment in levodopa-treated Parkinson's disease. Goetz CG; Stebbins GT; Blasucci LM Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412 [TBL] [Abstract][Full Text] [Related]
5. The patient's perspective: The effect of levodopa on Parkinson symptoms. Zach H; Dirkx M; Pasman JW; Bloem BR; Helmich RC Parkinsonism Relat Disord; 2017 Feb; 35():48-54. PubMed ID: 27919585 [TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of action tremor in Parkinson disease. Louis ED; Levy G; Côte LJ; Mejia H; Fahn S; Marder K Arch Neurol; 2001 Oct; 58(10):1630-4. PubMed ID: 11594921 [TBL] [Abstract][Full Text] [Related]
7. Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa. Marsden CD Drugs; 1998; 55 Suppl 1():17-22. PubMed ID: 9483166 [TBL] [Abstract][Full Text] [Related]
8. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease. Yamada K; Goto S; Hamasaki T; Kuratsu JI Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867 [TBL] [Abstract][Full Text] [Related]
9. Levodopa changes the severity of freezing in Parkinson's disease. Fietzek UM; Zwosta J; Schroeteler FE; Ziegler K; Ceballos-Baumann AO Parkinsonism Relat Disord; 2013 Oct; 19(10):894-6. PubMed ID: 23642712 [TBL] [Abstract][Full Text] [Related]
10. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation. Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889 [TBL] [Abstract][Full Text] [Related]
11. Does levodopa slow or hasten the rate of progression of Parkinson's disease? Fahn S; J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436 [TBL] [Abstract][Full Text] [Related]